Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 293296, 8 pages
http://dx.doi.org/10.1155/2013/293296
Research Article

Association of Self-DNA Mediated TLR9-Related Gene, DNA Methyltransferase, and Cytokeratin Protein Expression Alterations in HT29-Cells to DNA Fragment Length and Methylation Status

12nd Department of Internal Medicine, Semmelweis University, Szentkirályi Street 46, Budapest 1088, Hungary
2Molecular Medicine Research Unit, Hungarian Academy of Sciences, Nádor Street 7, Budapest 1051, Hungary
31st Department of Pathology and Experimental Oncology, Semmelweis University, Üllői Street 26, Budapest 1085, Hungary

Received 22 August 2013; Accepted 18 October 2013

Academic Editors: T. Goldmann and G. Szabo

Copyright © 2013 István Fűri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Gosu, S. Basith, O. P. Kwon, and S. Choi, “Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling,” Molecules, vol. 17, pp. 13503–13529, 2012. View at Google Scholar
  2. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Google Scholar · View at Scopus
  3. S. Nierkens, M. H. den Brok, Z. Garcia et al., “Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells,” Cancer Research, vol. 71, no. 20, pp. 6428–6437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Liang, E. A. Moseman, M. A. Farrar et al., “Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells,” Blood, vol. 115, no. 24, pp. 5041–5052, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Sipos and G. Muzes, “Isolated lymphoid follicles in colon: switch points between inflammation and colorectal cancer?” World Journal of Gastroenterology, vol. 17, no. 13, pp. 1666–1673, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Fischer and M. Ehlers, “Toll-like receptors in autoimmunity,” Annals of the New York Academy of Sciences, vol. 1143, pp. 21–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. B. Ewaschuk, J. L. Backer, T. A. Churchill, F. Obermeier, D. O. Krause, and K. L. Madsen, “Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA,” Infection and Immunity, vol. 75, no. 5, pp. 2572–2579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Lee, J. H. Mo, K. Katakura et al., “Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells,” Nature Cell Biology, vol. 8, no. 12, pp. 1327–1336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Akira and H. Hemmi, “Recognition of pathogen-associated molecular patterns by TLR family,” Immunology Letters, vol. 85, no. 2, pp. 85–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Kanzler, F. J. Barrat, E. M. Hessel, and R. L. Coffman, “Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists,” Nature Medicine, vol. 13, no. 5, pp. 552–559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. H. Kauppila, T. J. Karttunen, J. Saarnio, P. Nyberg, T. Salo, and D. E. Graves, “Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion,” APMIS, vol. 121, no. 6, pp. 511–522, 2013. View at Publisher · View at Google Scholar
  12. H. Häcker, H. Mischak, T. Miethke et al., “CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation,” The EMBO Journal, vol. 17, no. 21, pp. 6230–6240, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Klaschik, D. Tross, and D. M. Klinman, “Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo,” Journal of Leukocyte Biology, vol. 85, no. 5, pp. 788–795, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. I. Ito, K. J. Ishii, H. Shirota, and D. M. Klinman, “CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection,” Infection and Immunity, vol. 72, no. 6, pp. 3543–3548, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Verthelyi, M. Gursel, R. T. Kenney et al., “CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection,” The Journal of Immunology, vol. 170, no. 9, pp. 4717–4723, 2003. View at Google Scholar · View at Scopus
  16. S. Klaschik, D. Tross, H. Shirota, and D. M. Klinman, “Short- and long-term changes in gene expression mediated by the activation of TLR9,” Molecular Immunology, vol. 47, no. 6, pp. 1317–1324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Ilvesaro, M. A. Merrell, L. Li et al., “Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion,” Molecular Cancer Research, vol. 6, no. 10, pp. 1534–1543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Huidobro, R. G. Urdinguio, R. M. Rodríguez et al., “A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer,” European Journal of Cancer, vol. 48, pp. 2270–2281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Renbaum, D. Abrahamove, A. Fainsod, G. G. Wilson, S. Rottem, and A. Razin, “Cloning, characterization, and expression in Escherichia coli of the gene coding for the CpG DNA methylase from Spiroplasma sp. strain MQ1 (M·SssI),” Nucleic Acids Research, vol. 18, no. 5, pp. 1145–1152, 1990. View at Google Scholar · View at Scopus
  20. J. M. Ilvesaro, M. A. Merrell, T. M. Swain et al., “Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro,” Prostate, vol. 67, no. 7, pp. 774–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. M. Schaefer, K. Desouza, J. V. Fahey, K. W. Beagley, and C. R. Wira, “Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells,” Immunology, vol. 112, no. 3, pp. 428–436, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Schmaußer, M. Andrulis, S. Endrich, H. K. Müller-Hermelink, and M. Eck, “Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori,” International Journal of Medical Microbiology, vol. 295, no. 3, pp. 179–185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Droemann, D. Albrecht, J. Gerdes et al., “Human lung cancer cells express functionally active Toll-like receptor 9,” Respiratory Research, vol. 6, article 1, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Merrell, J. M. Ilvesaro, N. Lehtonen et al., “Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity,” Molecular Cancer Research, vol. 4, no. 7, pp. 437–447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Hemmi, O. Takeuchi, T. Kawai et al., “A Toll-like receptor recognizes bacterial DNA,” Nature, vol. 408, no. 6813, pp. 740–745, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. Eads, K. D. Danenberg, K. Kawakami, L. B. Saltz, P. V. Danenberg, and P. W. Laird, “CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression,” Cancer Research, vol. 59, no. 10, pp. 2302–2306, 1999. View at Google Scholar · View at Scopus
  27. B. K. Oh, H. Kim, H. J. Park et al., “DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation,” International Journal of Molecular Medicine, vol. 20, no. 1, pp. 65–73, 2007. View at Google Scholar · View at Scopus
  28. W.-J. Ding, J.-Y. Fang, X.-Y. Chen, and Y.-S. Peng, “The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer,” Digestive Diseases and Sciences, vol. 53, no. 8, pp. 2083–2089, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Y. Fang, R. Lu, J. A. Mikovits, Z. H. Cheng, H. Y. Zhu, and Y. X. Chen, “Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1,” Cancer Letters, vol. 233, no. 1, pp. 124–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. T. M. Geiman, U. T. Sankpal, A. K. Robertson et al., “Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery,” Nucleic Acids Research, vol. 32, no. 9, pp. 2716–2729, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Y. Fang, Z. H. Cheng, Y. X. Chen et al., “Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer,” World Journal of Gastroenterology, vol. 10, no. 23, pp. 3394–3398, 2004. View at Google Scholar · View at Scopus
  32. M. Fabbri, R. Garzon, A. Cimmino et al., “MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 40, pp. 15805–15810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Singh, P. Sharma, and N. Capalash, “DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer,” Current Cancer Drug Targets, vol. 13, no. 4, pp. 379–399, 2013. View at Google Scholar